[Pharmaceutic incompatibilities].
D001665:Binding Sites; D004338:Drug Combinations / Q000009:adverse effects*; D004344:Drug Incompatibility; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D010084:Oxidation-Reduction
D004338:Drug Combinations
Pharmazeutische Inkompatibilitäten.